Kimal Honour Djam

Title: Kimal Honour Djam: Innovator in Cancer Radiation Therapy

Introduction

Kimal Honour Djam is a notable inventor based in Southfield, MI (US). He has made significant contributions to the field of cancer treatment through his innovative approach to radiation therapy. His work focuses on utilizing biocompatible quantum dots to enhance the effectiveness of radiation therapy for cancerous tumors.

Latest Patents

Djam holds a patent for a groundbreaking method titled "Cancer radiation therapy with biocompatible quantum dots for simultaneous dose enhancement and counter-metastasis." This patent describes systems and methods for radiation therapy that utilize biocompatible quantum dots to provide both radiation dose enhancement and resistance to metastasis. The method involves preparing a radiosensitizer fluid containing a plurality of biocompatible quantum dots, introducing this fluid to cancer cells, and subsequently irradiating the cells to promote the generation of reactive oxygen species while inhibiting radiation-induced enhancement of cell migration.

Career Highlights

Kimal Honour Djam is affiliated with Creighton University, where he continues to advance his research in cancer therapy. His innovative work has the potential to significantly improve treatment outcomes for patients suffering from cancer.

Collaborations

Djam collaborates with several talented individuals in his field, including Andrew Edet Ekpenyong and Caleb Thiegs. These collaborations enhance the research and development of new therapeutic methods.

Conclusion

Kimal Honour Djam's contributions to cancer radiation therapy exemplify the impact of innovative thinking in medical science. His work with biocompatible quantum dots represents a promising advancement in the fight against cancer.